cfDNA 5mC/5hmC Biomarkers to Predict Chemotherapy Response in Metastatic Colorectal Cancer

NCT07224815 · clinicaltrials.gov ↗

RECRUITING

Status

600

Enrollment

OTHER

Sponsor class

Conditions

CRC (Colorectal Cancer)

Interventions

DIAGNOSTIC_TEST: cfDNA 5mC/5hmC Sequencing (EpiCORE Discovery Phase)
DIAGNOSTIC_TEST: EpiCORE Assay (Targeted Sequencing / qPCR Validation)

Sponsor

City of Hope Medical Center